From July 1, 2020 to September 30, 2020, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 69,714 shares, representing 0.11% for KRW 918.87 million under the buyback announced on March 13, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,535 KRW | -1.36% |
|
-2.69% | -17.96% |
May. 20 | HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
May. 20 | HLB bioStep Co.,Ltd. authorizes a Buyback Plan. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.96% | 159M | |
-42.93% | 7.63B | |
+11.18% | 3.73B | |
-2.64% | 2.26B | |
-21.65% | 1.98B | |
-23.66% | 1.63B | |
+6.87% | 959M | |
-7.21% | 720M | |
+14.42% | 705M | |
-37.65% | 463M |
- Stock Market
- Equities
- A278650 Stock
- News HLB bioStep Co.,Ltd.
- Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.